Viewing Study NCT02586051


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-02-22 @ 6:43 PM
Study NCT ID: NCT02586051
Status: COMPLETED
Last Update Posted: 2020-01-29
First Post: 2015-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module